{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Indiana",
      "state": "PA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "90134",
      "recalling_firm": "RemedyRepack Inc.",
      "address_1": "625 Kolter Dr Ste 4",
      "address_2": "",
      "postal_code": "15701-3571",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Recalled product was distributed to Florida.",
      "recall_number": "D-0885-2022",
      "product_description": "Losartan HCTZ 50/12.5 mg, 90 count bottle  Original NDC# 33342-0050-10  Repackaged NDC# 70518-3231-00",
      "product_quantity": "22 bottles/90 count each",
      "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits",
      "recall_initiation_date": "20220504",
      "center_classification_date": "20220520",
      "termination_date": "20220902",
      "report_date": "20220601",
      "code_info": "Lot #  B1377711-100521, exp. date 10/31/2022  B1412137-102621, exp. date 10/31/2022",
      "more_code_info": ""
    }
  ]
}